Nothing said here yet.
to join the conversation.
| KERREY J ROBERTDirector | Sell | 5,483 | $1.4M | Mon, Sep 14 |
| KERREY J ROBERTDirector | Sell | 4,025 | $1.1M | Mon, Sep 14 |
| KERREY J ROBERTDirector | Sell | 2,502 | $662.1K | Mon, Sep 14 |
| MARK RICHARD JDirector | Sell | 10,000 | $2.6M | Thu, Sep 10 |
| West NadjaDirector | Sell | 1,152 | $298.1K | Wed, Sep 2 |
| Foo Lisa YEVP, Chief Operating Officer | Sell | 24,000 | $6.4M | Mon, Aug 31 |
| Sutaria SaumyaCEO | Sell | 24,881 | $6.8M | Tue, Aug 25 |
| Sutaria SaumyaCEO | Sell | 17,220 | $4.7M | Tue, Aug 25 |
| Sutaria SaumyaCEO | Sell | 7,899 | $2.2M | Tue, Aug 25 |
| Sutaria SaumyaCEO | Sell | 36,656 | $10.2M | Mon, Aug 24 |
| Sutaria SaumyaCEO | Sell | 13,344 | $3.7M | Mon, Aug 24 |
| HANEY CECIL DDirector | Sell | 1,300 | $361.4K | Mon, Aug 24 |
| Jonathan Jackson | Sell | $32.5K | Mon, Apr 20 | Fri, May 8 |
| Jonathan Jackson | Sell | $8.0K | Wed, Apr 15 | Fri, May 8 |
Tenet Healthcare has turned into one of the stronger performers in the hospital sector over recent years, which naturally raises a sharper question for investors.
Tenet Healthcare reported third quarter 2026 sales of US$5.63b and net income of US$1.0b, alongside nine month net income of US$2.53b, and raised full year guidance for revenue, earnings and diluted EPS.
Tenet Healthcare (THC) moved into focus after management raised full year 2026 earnings guidance, following third quarter results that paired higher revenue with much stronger net income and earnings per share.
Tenet Healthcare (NYSE:THC) reported third-quarter 2026 net operating revenue of $5.6 billion and consolidated adjusted EBITDA of $1.355 billion, while adjusted diluted earnings per share rose 80% from a year earlier to $6.64.
The health system's push into high-acuity procedures like joint replacements and spinal fusions helped offset declining surgical volumes and payer mix pressures tied to the ACA exchanges.
Tenet Healthcare raises its 2026 outlook as Q3 earnings surge, hospital margins improve and higher-acuity care drives ambulatory growth despite payer pressures.
Moby summary of Tenet Healthcare Corporation's Q3 2026 earnings call
EPS surged 79.5% on high-acuity demand and transition benefits.
Tenet Healthcare's Q3 earnings surge 79.5% on strong hospital performance and cost discipline, prompting higher 2026 EPS and EBITDA guidance.
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.